Trade Mark Journal No.2026/046 13 November 2026
UK00004468051 30 October 2026 (9,10)
UVISA
- Class 9
- Downloadable software; Downloadable application software; Downloadable application software for use in connection with medical devices, including medical devices for treating or diagnosing vaginal and vulvar discomfort and infections such as bacterial vaginosis and candidiasis; Downloadable application software for controlling, tracking, monitoring, and managing medical devices, including medical devices for treating or diagnosing vaginal and vulvar discomfort and infections such as bacterial vaginosis and candidiasis; Downloadable application software for receiving, recording, collecting, storing, processing, analysing, displaying and transmitting data from medical devices; Downloadable application software for tracking, monitoring, and generating health and medical information and reports; Downloadable application software enabling users to access, track, monitor, and generate health and medical information and reports; Downloadable application software for providing users with information relating to health, healthcare, medical conditions and medical treatments; Downloadable application software for the collection, management, analysis, and sharing of health and medical data; Software as a medical device [SaMD]; Sensors; Batteries and chargers; Parts and fittings for the aforementioned goods.
- Class 10
- Medical and veterinary apparatus and instruments; Medical diagnostic, examination, and monitoring equipment; Physical therapy equipment; Medical devices, apparatus, and instruments for treating or diagnosing vaginal and vulvar discomfort and infections such as bacterial vaginosis and candidiasis; Medical devices, apparatus, and instruments, including with embedded hardware and software, for treating or diagnosing vaginal and vulvar discomfort and infections such as bacterial vaginosis and candidiasis; Apparatus for phototherapy; Parts and fittings for the aforementioned goods.
Uvisa Health ApS
Representative: Venner Shipley LLP